Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors (Q27853208)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors |
scientific article |
Statements
Barry R Davies
Nin Guan
Armelle Logie
Claire Crafter
Lyndsey Hanson
Vivien Jacobs
Neil James
Philippa Dudley
Kelly Jacques
Brendon Ladd
Celina M D'Cruz
Michael Zinda
Makoto Kodaira
Kenji Tamura
November 2015
0 references
Identifiers
2 references
2 references